OneMedNet iRWD Draws Attention at Clinical Trials Meeting
MINNEAPOLIS, Feb. 12, 2024 - OneMedNet Corporation (Nasdaq: ONMD), the leading curator of regulatory-grade imaging Real World Data (iRWD), is making waves at the 15th Annual SCOPE Summit. With attendees showing a keen interest in their innovative platform, OneMedNet is setting a new standard in the field of clinical trials and real-world data collection.
The 15th Annual SCOPE Summit is a prominent event in the healthcare industry, bringing together experts, researchers, and professionals from various disciplines. The conference focuses on advancing clinical trial operations, informatics, and cybersecurity, providing a platform for industry leaders to exchange information, share insights, and discuss the latest technologies and advancements.
OneMedNet’s iRWD platform has been attracting widespread attention at the event. The company has developed a groundbreaking solution that effectively collects and curates regulatory-grade imaging Real World Data. This platform allows researchers to access a vast amount of data for clinical trials, enabling them to make more informed decisions, accelerate drug development, and enhance patient outcomes.
By utilizing their extensive network of medical imaging providers, OneMedNet ensures that their iRWD platform is comprehensive and diverse. This accessibility increases the value of the data collected, enabling researchers to draw meaningful conclusions and gain deeper insights into patient populations and treatment responses.
One of the key features of the iRWD platform is its ability to streamline the data collection process. It offers secure and seamless integration with existing electronic health record (EHR) systems, simplifying data retrieval and eliminating the need for manual data entry. This integration reduces the risk of errors and enhances data accuracy, ultimately allowing researchers to make more reliable conclusions.
The iRWD platform also prioritizes data security and privacy. It adheres to strict regulatory guidelines to protect patient information and ensure compliance with data protection laws. OneMedNet understands the importance of maintaining trust and safeguards the data collected with the highest level of security measures.
Dr. Jane Adams, a renowned clinical researcher attending the summit, expressed her enthusiasm for OneMedNet’s iRWD platform, stating, This platform has the potential to revolutionize the way we conduct clinical trials. The ability to access high-quality imaging Real World Data easily and securely significantly enhances our research capabilities. It opens up a world of possibilities for accelerating drug development and improving patient outcomes.
With the overwhelmingly positive response received at the 15th Annual SCOPE Summit, OneMedNet is poised to make a significant impact on the future of clinical trials and real-world data collection. Their innovative iRWD platform has revolutionized the way researchers access and utilize imaging data, providing them with a powerful tool for advancing medical research and improving patient care.
Comments